Anti-FGFR1/ BFGFR/ CD331 monoclonal antibody

Anti-FGFR1/ BFGFR/ CD331 antibody for FACS & in-vivo assay

Target products collectionGo to FGFR1/FGFR1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T47101-Ab-1/ GM-Tg-hg-T47101-Ab-2Anti-Human FGFR1 monoclonal antibodyHuman
GM-Tg-rg-T47101-Ab-1/ GM-Tg-rg-T47101-Ab-2Anti-Rat FGFR1 monoclonal antibodyRat
GM-Tg-mg-T47101-Ab-1/ GM-Tg-mg-T47101-Ab-2Anti-Mouse FGFR1 monoclonal antibodyMouse
GM-Tg-cynog-T47101-Ab-1/ GM-Tg-cynog-T47101-Ab-2Anti-Cynomolgus/ Rhesus macaque FGFR1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T47101-Ab-1/ GM-Tg-felg-T47101-Ab-2Anti-Feline FGFR1 monoclonal antibodyFeline
GM-Tg-cang-T47101-Ab-1/ GM-Tg-cang-T47101-Ab-2Anti-Canine FGFR1 monoclonal antibodyCanine
GM-Tg-bovg-T47101-Ab-1/ GM-Tg-bovg-T47101-Ab-2Anti-Bovine FGFR1 monoclonal antibodyBovine
GM-Tg-equg-T47101-Ab-1/ GM-Tg-equg-T47101-Ab-2Anti-Equine FGFR1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T47101-Ab-1/ GM-Tg-hg-T47101-Ab-2; GM-Tg-rg-T47101-Ab-1/ GM-Tg-rg-T47101-Ab-2;
GM-Tg-mg-T47101-Ab-1/ GM-Tg-mg-T47101-Ab-2; GM-Tg-cynog-T47101-Ab-1/ GM-Tg-cynog-T47101-Ab-2;
GM-Tg-felg-T47101-Ab-1/ GM-Tg-felg-T47101-Ab-2; GM-Tg-cang-T47101-Ab-1/ GM-Tg-cang-T47101-Ab-2;
GM-Tg-bovg-T47101-Ab-1/ GM-Tg-bovg-T47101-Ab-2; GM-Tg-equg-T47101-Ab-1/ GM-Tg-equg-T47101-Ab-2
Products NameAnti-FGFR1 monoclonal antibody
Formatmab
Target NameFGFR1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FGFR1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-INN-826Pre-Made Efruxifermin Biosimilar, Fusion Protein targeting FGFR1 fused with human IGHG1 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting BFGFR/CD331/CEK/ECCL/FGFBR/FGFR-1/FLG/FLT-2/FLT2/HBGFR/HH2/HRTFDS/KAL2/N-SAM/OGD/bFGF-R-1
    Target AntigenProducts DevelopingMulti-species FGFR1/ BFGFR/ CD331 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-T47101-Ag-1Fibroblast growth factor receptor 1 (FGFR1) protein
    ORF Viral VectorpGMLP003322human FGFR1 Lentivirus plasmid
    ORF Viral VectorvGMLP003322human FGFR1 Lentivirus particle
    ORF Viral VectorpGMLPm001261mouse Fgfr1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001261mouse Fgfr1 Lentivirus particle


    Target information

    Target IDGM-T47101
    Target NameFGFR1
    Gene ID2260,14182,79114,700126,100856477,101086055,281768,100057614
    Gene Symbol and SynonymsbFGF-R,bFGF-R-1,BFGFR,c-fgr,CD331,CEK,Eask,ECCL,FGFBR,FGFR-1,FGFR-I,FGFR1,FGFRI,FLG,FLG-1,FLT-2,FLT2,Fr1,HBGFR,HH2,HRTFDS,Hspy,KAL2,MFR,N-SAM,OGD
    Uniprot AccessionP11362,Q04589
    Uniprot Entry NameFGFR1_HUMAN,FGFR1_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, INN Index, Cytokine Target
    DiseaseJuvenile astrocytoma
    Gene EnsemblENSG00000077782
    Target ClassificationKinase

    The target: FGFR1, gene name: FGFR1, also named as BFGFR, CD331, CEK, ECCL, FGFBR, FGFR-1, FLG, FLT-2, FLT2, HBGFR, HH2, HRTFDS, KAL2, N-SAM, OGD, bFGF-R-1. The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. Mutations in this gene have been associated with Pfeiffer syndrome, Jackson-Weiss syndrome, Antley-Bixler syndrome, osteoglophonic dysplasia, and autosomal dominant Kallmann syndrome 2. Chromosomal aberrations involving this gene are associated with stem cell myeloproliferative disorder and stem cell leukemia lymphoma syndrome. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.